Safety of cetirizine ophthalmic solution 0.24% for the treatment of allergic conjunctivitis in adult and pediatric subjects

PURPOSE: The studies reported here aimed to assess the safety and tolerability of cetirizine ophthalmic solution 0.24%, a new topical ophthalmic medication approved by the US Food and Drug Administration for the treatment of ocular itching associated with allergic conjunctivitis. PATIENTS AND METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Malhotra, Ranjan P, Meier, Edward, Torkildsen, Gail, Gomes, Paul J, Jasek, Mark C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387590/
https://www.ncbi.nlm.nih.gov/pubmed/30858690
http://dx.doi.org/10.2147/OPTH.S186092

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387590/
https://www.ncbi.nlm.nih.gov/pubmed/30858690
http://dx.doi.org/10.2147/OPTH.S186092

Ejemplares similares